Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Early-stage biotech developing drug candidates using a proprietary HDACi platform based on Largazole analogs
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |